Get the latest Science News and Discoveries
3-year study of tirzepatide shows that most patients only gain 5% or less from their lowest or ‘nadir’ weight - EurekAlert!
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
None
Or read this on Eureka Alert